The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

A new report shows the five-year survival rate for all cancers reached a historic 70%. About 2.1 million new cancer diagnoses ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

"Seven in 10 people now survive their cancer 5 years or more, up from only half in the mid-70s," Siegel said in a press ...

The Prostate Cancer Foundation has partnered with the Naismith Basketball Hall of Fame to host the launch of their “Check the ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

Medanta – The Medicity has launched a prostate cancer awareness initiative titled ‘Socho Mat Baat Karo’ (SMBK). The campaign ...

Urology, Ramaiah Institute of Nephro-Uro Sciences, Ramaiah Memorial Hospital, explains how robotic and minimally invasive ...

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...